Ixabepilone in Treating Patients With Recurrent or Persistent Endometrial Cancer

Clinical trial NCT00095979 · COMPLETED

Trial details

NCT number: NCT00095979
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Endometrial Adenocarcinoma Recurrent Endometrial Carcinoma Stage IV Endometrial Carcinoma

Start date: 2005-05-01
Primary completion: 2009-07-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.